Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
Price
Gainers & Losers
Weekly Gainers & Losers
Monthly Gainers & Losers
Super/Mega Movers
Out & Under Performers
Advances & Declines
Only Buyers / Sellers
Value Toppers
Arbitrage Opportunity
New Highs / Lows
52 Week Highs / Lows
LifeTime Highs / Lows
Exchange Turnover
Historical Return
Exchange Holidays
Volume
Volume Toppers
Block Deals
Bulk Deals
Highest & Lowest Delivery
Delivery Shockers
Unusual Volume Up/Down
Exchange Volume
Analysis
5 Day's Up/Down
Rising VDP
Rising VD Fall in P
Price Shockers
Indian Indices
Profit Report
Income Report
Industry Performance
Market Turnover Scripwise
Sector Watch
Special Tools
Above Moving Avarage
Below Moving Avarage
Bullish Reversal
Gap Up
Gap Down
Higher Opening
Lower Opening
Stocks < Previous Highs
Stocks < Previous Low
  News Analysis
Hot Stocks
Other Market
Corporate News
Market Pulse
Economy
Company Result
FII Position
Opening Bell
Midday Review
Closing Bell
Stock News
Global News
  Corporate Action
BSE / NSE Announcements
Book Closures
Board Meetings
Bonus Issues
Dividend Details
Right Issues
Corporate Results
Delisted Shares
Split of Face Value
Change of Name
Mergers
Demergers
  Other Market
FII Investments
DII Investments
World Indices
ADR Prices
Forex
  Company Profile
Company Details
Smart Quote
Share Prices
Company Background
Board Members
MF Holdings
Company News
Peer Companies News
Financials
Profit & Loss
Balance Sheet
Cash Flow
Financial Ratios
Share Holdings Pattern
Results
Quaterly
Quick Review
Company Reports
Director's Report
Derivatives
IPO
BSE Smart Quote
Glenmark Pharmaceuticals Ltd.
BSE Code 532296
ISIN Demat INE935A01035
Book Value (Rs) 868.32
NSE Code GLENMARK
Dividend Yield % 0.11
Market Cap(Rs Mn) 615635.17
TTM PE(x) 38.23
TTM EPS(Rs) 57.06
Face Value (Rs) 1  
 
Jul 11, 2025
Last Price  2181.55  
Prev.Close  1905.15  
Net Change  276.4  
52-Week High  2286.15  
Open  2095.65  
High  2286.15  
Low   2095.65
52-Week Low  1274.70  
 
1 D | 1 M | 3 M | 1 Y
Stock Return Performance (in %) M Cap Sales
  Company Name 1W 1M 6M 1Y
Glenmark Pharma   19   33   46   58
Sun Pharma Inds.   0   -1   -4   6
Divi's Lab   -1   2   19   49
Cipla   -2   -2   3   -1
Torrent Pharma   -2   3   2   12
BSE HC   -1   1   4   15
 Company Name 1W 1M 6M 1Y
Glenmark Pharma   19   33   46   58
Dr. Reddy's Lab   -4   -7   -6   -5
Sun Pharma Inds.   0   -1   -4   6
Cipla   -2   -2   3   -1
Lupin   -4   -7   -12   4
BSE HC   -1   1   4   15
Sensex   -1   0   8   3
 
News
More
Key Maket Ratio
Latest EPS 57.06 MktCap/Sales 6.83
Latest CEPS 65   P/CEPS 34
Price / BV 2.51 Price / Sales 0.02
EV / EBIDTA 23.89 EV / Sales 6.90
Div Yield % 0.11    
Results Standalone Consolidated
TTM Latest 4 Quarters Quarter on Quarter
Particulars Prev.TTM
Net Sales  78911 
PBDIT 12417 
PAT 51673 
EPS 183 
Mar 2025Dec 2024Sep 2024Jun 2024
20095225132636123295
3405493977866311
1478413859514537
5152116
Mar 2024  Var %
21482  -6 
4974  -32 
46137  -97 
164  -97 
TTM Latest 4 Quarters Quarter on Quarter
Particulars Prev.TTM
Net Sales  121786 
PBDIT 13892 
PAT -16954 
EPS -63 
Mar 2025Dec 2024Sep 2024Jun 2024
32562338763433832442
5610600260195882
44348035453402
0121312
Mar 2024  Var %
30630  6 
5043  11 
-12386  -100 
-44  -100 
MF Holding Details
 
Competitors
 Peer CompaniesLTP%Chg
Neuland Laboratories 12306 3.39
Astrazeneca Pharma I 9237.05 1.4
Procter&Gamble Healt 5777.05 1.65
Alkem Laboratories 4806.95 1.53
Wockhardt 1756.75 3.51
Disclaimer  |  Privacy Policy  |  Rules and Regulation  |  Terms Of Use     Copyright 2008-2009 IITGROUP
Designed | Developed & Content Powered By www.accord.com ACCORD FINTECH